Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2023-04-05 Regulatory Filings
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Business update for PSE and CiRT tests
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a date (05 April 2023) and company information (Oxford BioDynamics PLC). The content is a 'Business update' detailing progress on product launches (PSE test) and sales traction (CiRT test), along with operational updates (leasing lab space). This format—a brief announcement providing operational and commercial highlights, often referencing previous results or future plans, and distributed via RNS—is characteristic of a general regulatory announcement or business update that doesn't fit the specific definitions of an Earnings Release (ER) or Interim Report (IR). Since it is a formal announcement distributed through the RNS system and provides general business news rather than specific financial statements or management compensation details, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category.
2023-04-05 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states 'Result of AGM' and mentions that 'all resolutions at the Company's Annual General Meeting, held earlier today, were duly passed.' This directly relates to the outcome of the Annual General Meeting. The appropriate classification code for AGM-related results or materials is AGM-R.
2023-03-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains the standard formatting for notifications distributed via RNS (Regulatory News Service) of the London Stock Exchange. The content details a 'TR-1: Standard form for notification of major holdings' concerning an 'acquisition or disposal of voting rights' by an individual shareholder, Christian Gurth Hoyer Millar, crossing a threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although RNS is mentioned, the specific content is a detailed regulatory disclosure about share ownership change, making MRQ the most precise classification over the general RNS fallback.
2023-03-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' notification from the 'National Storage Mechanism' and is dated March 22, 2023. The content is a 'TR-1: Standard form for notification of major holdings' concerning an acquisition or disposal of voting rights by a shareholder (Philippa Margaret Hoyer Millar). This type of mandatory disclosure regarding changes in significant share ownership thresholds directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-03-22 English
Group of companies' accounts made up to 2022-09-30
Regulatory Filings
2023-03-21 English
AIM Rule 17 Schedule 2(g) Update
Board/Management Information Classification · 99% confidence The document starts with 'RNS Number' and is dated March 15, 2023. The content explicitly states it is an 'AIM Rule 17 Schedule 2(g) Update' regarding a director's past involvement with a liquidated company. This type of disclosure, mandated by the London Stock Exchange's AIM rules, is a regulatory announcement. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific transaction report (like DIRS or POS), and it is clearly a formal regulatory notification distributed via RNS, the most appropriate classification is Regulatory Filings (RNS). The document length (5521 chars) is substantial enough that it is not just a placeholder announcement (RPA), but the content itself is a specific regulatory disclosure.
2023-03-15 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.